CNBC: Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine “Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases,…

CATO Institute: The COVID Vaccine Trials & the Role of Government in Public Health Terence Kealey, adjunct scholar at the CATO Institute and professor of clinical biochemistry at the University of Buckingham (11/18). Center for Global Development: Realizing Savings from Better Procurement Today to Build Resilient Health Systems for Tomorrow…

The Atlantic: The End of the Pandemic Is Now in Sight “…Even as science began to unravel many of the virus’s mysteries — how it spreads, how it tricks its way into cells, how it kills — a fundamental unknown about vaccines hung over the pandemic and our collective human…

CIDRAP News: Wellcome calls for more focused antimicrobial resistance agenda “…[W]hile there’s been a lot of talk about AMR in the ensuing years [since the United Nations (U.N.) high-level meeting on AMR in 2016], there hasn’t been as much action. And even before the COVID-19 pandemic became the biggest public…

Devex: Opinion: How AI can push for equitable access to COVID-19 vaccines Jayasree Iyer, executive director, and Thomas Collin-Lefebvre, researcher to the executive director, both at the Access to Medicine Foundation (11/18). Devex: Opinion: Why exciting results from vaccine research are just the beginning of efforts to end COVID-19 Mitchell…

Devex: Children as superspreaders of malaria “New research from Uganda found that asymptomatic, school-aged children can serve as superspreaders of malaria. These findings suggest that efforts to eliminate the disease from countries might be harder than previously thought. The findings, which were presented at the annual meeting of the American…

The Conversation: Buying and distributing a COVID-19 vaccine will involve hard ethical and practical choices Barbara Allen, senior lecturer in public management, and Michael Macaulay, professor of public administration, both at Te Herenga Waka — Victoria University of Wellington (11/17). The Conversation: Virus evolution could undermine a COVID-19 vaccine –…

New York Times: New Pfizer Results: Coronavirus Vaccine Is Safe and 95% Effective “The drug maker Pfizer said on Wednesday that its coronavirus vaccine was 95 percent effective and had no serious side effects — the first set of complete results from a late-stage vaccine trial as Covid-19 cases skyrocket…

Reuters: World should not be complacent after COVID-19 vaccine news: WHO “The World Health Organization (WHO) welcomed Moderna reporting on Monday that its experimental vaccine showed 94.5% efficacy but said that ‘many questions’ remained and it was no time for complacency…” (Nebehay/Farge, 11/16). Reuters: WHO sees limited COVID-19 vaccine doses…

Washington Post: Moderna’s coronavirus vaccine found to be nearly 95 percent effective in a preliminary analysis “Biotechnology firm Moderna announced Monday that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95 percent effective at preventing illness, including severe cases — a striking initial result that leaves the United…